Early functional SARS-CoV-2-specific T cell response may prevent severe infection
UK hits COVID vaccination ‘landmark’ in care homes
1 February 2021New insights into B cells and why humans can produce trillions of disease-fighting antibodies
1 February 2021Early functional SARS-CoV-2-specific T cell response may prevent severe infection
Antibodies and T cells are components of the human immune system that directly act against viral infections and eliminate infected cells. A new study by scientists from Duke-NUS Medical School, provides evidence that an early presence of SARS-CoV-2-specific T cells in COVID-19 is likely to prevent severe disease. The study, published in Cell Reports, has important implications for the clinical management of COVID-19 patients.
